Stockreport

Verona started at overweight by Wells Fargo, says COPD drug undervalued [Seeking Alpha]

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time
PDF The investment bank said the market has been pricing in peak sales of around $750M for the drug, but early feedback from prescribers suggests the drug could generate ro [Read more]